Table 1.
<Hemi-hepatectomy + Distal (n = 224) | ≥Hemi-hepatectomy + Distal (n = 49) | <Hemi-hepatectomy + PD (n = 183) | ≥Hemi-hepatectomy + PD (n = 24) | P-value | |
---|---|---|---|---|---|
Age | 58 (21–84) | 58 (20–86) | 64 (25–88) | 53 (26–78) | 0.001 |
Race | |||||
White | 170 (75.9) | 35 (71.4) | 144 (78.7) | 17 (70.8) | 0.460 |
Black | 26 (11.6) | 5 (10.2) | 12 (6.6) | 2 (8.3) | |
Asian | 9 (4.0) | 3 (6.1) | 14 (7.7) | 2 (8.3) | |
Other | 19 (8.5) | 6 (12.2) | 13 (7.1) | 3 (12.5) | |
Female | 129 (57.6) | 24 (49) | 191 (55.2) | 9 (37.5) | 0.232 |
BMI | 28 (16–68) | 26 (17–40) | 27 (17–50) | 26 (17–40) | 0.071 |
Any Comorbidity (n = 380) | 45 (26.5) | 6 (16.2) | 37 (24.5) | 3 (15.8) | 0.528 |
Smoker | 27 (12.1) | 7 (14.3) | 32 (17.5) | 1 (4.2) | 0.213 |
Diabetes | 43 (19.2) | 3 (6.1) | 35 (19) | 3 (12.5) | 0.114 |
COPD | 5 (2.2) | 2 (4.1) | 7 (3.8) | 0 (0) | 0.652 |
HTN on medication | 104 (46.4) | 14 (28.6) | 91 (49.7) | 6 (25) | 0.011 |
TIA (n = 273) | 2 (1.6) | 0 (0) | 0 (0) | 0 (0) | 0.656 |
CVA (n-273) | 1 (0.8) | 0 (00 | 2 (1.9) | 0 (0) | 0.766 |
Sepsis | 4 (1.8) | 3 (6.1) | 6 (3.3) | 0 (0) | 0.303 |
Pre-operative chemotherapy (n = 272) | 5 (4.0) | 3 (10) | 8 (7.8) | 1 (6.3) | 0.423 |
Pre-operative Radiotherapy (n = 272) | 4 (3.2) | 0 (0) | 3 (1.9) | 0 (0) | 0.695 |
Creatinine | 0.8 (0.3–2.4) | 0.9 (0.4–1.6) | 0.8 (0.3–2.43) | 0.84 (0.6–1.3) | 0.472 |
Albumin | 3.9 (1–5.1) | 3.9 (2–4.8) | 3.8 (1.6–5) | 3.8 (2.1–5.1) | 0.109 |
Bilirubin | 0.6 (0.1–2.2) | 0.6 (0.1–8.9) | 0.6 (0.6–11.5) | 0.7 (0.1–8.9) | <0.001 |
Platelet | 228 (40–588) | 225 (106–428) | 250 (23–620) | 278 (166–590) | 0.011 |
INR | 1 (0.8–1.9) | 1 (0.8–1.7) | 1 (0.74–9.1) | 1 (0.91–1.2) | 0.878 |
ASA Class > 3 | 158 (70.5) | 37 (75.5) | 126 (68.9) | 20 (83.3) | 0.442 |
ASA, American Society of Anesthesiologist; TIA, transient ischaemic attack; HTN, hypertension; COPD, chronic obstructive pulmonary disease; BMI, body mass index; CVA, cerebral vascular attack; INR, International normalized ratio.